Solidwizard Technology Co., Ltd. (TPEX:8416)

Sage Therapeutics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,184	1,017	908.5	887.17	818.44	700.08
Trading Asset Securities	21.72	21.55	21.24	20.99	20.9	20.85
Cash & Short-Term Investments	1,209	1,038	929.74	908.17	839.34	720.93
Cash Growth	8.56%	11.69%	2.38%	8.20%	16.43%	16.84%
Receivables	362.69	481.67	432.31	434.33	467.5	424.63
Inventory	86.89	119.43	155.07	60	36.52	43.66
Prepaid Expenses	9.98	6.24	18.25	23.12	15.56	13.15
Other Current Assets	4.58	5.95	5.99	8.55	4.55	5.17
Total Current Assets	1,673	1,652	1,541	1,434	1,363	1,208
Property, Plant & Equipment	229.73	237.56	226.33	222.76	227.94	227.36
Long-Term Investments	25.8	25.8	25.8	25.8	-	-
Other Intangible Assets	0.39	0.78	1.36	0.98	22.05	22.34
Long-Term Deferred Tax Assets	11.97	11.74	12.86	13.06	12.79	14.13
Other Long-Term Assets	7.73	7.49	8.27	15.2	12.58	8.45
Total Assets	1,949	1,935	1,817	1,713	1,641	1,482
Accounts Payable	114.23	225.94	213.56	125.27	145.35	129.1
Accrued Expenses	-	93.66	84.11	91.01	93.18	96.1
Current Portion of Leases	4.38	5.06	3.92	3.58	5.37	4.39
Current Income Taxes Payable	41.14	40.73	38.1	44.62	43.63	40.02
Current Unearned Revenue	6.51	4.92	5.36	30.4	25.28	18.4
Other Current Liabilities	323.45	15.43	13.14	15.49	14.94	12.34
Total Current Liabilities	489.71	385.74	358.2	310.36	327.73	300.34
Long-Term Leases	0.5	2.4	3.76	1.3	4.88	5.25
Long-Term Unearned Revenue	-	-	-	8.92	10.01	5.62
Long-Term Deferred Tax Liabilities	24.29	27.04	23.21	21.59	15.77	10.49
Other Long-Term Liabilities	5.46	-	-	-	-	-
Total Liabilities	519.96	420.73	392.2	349.5	367.38	331.49
Common Stock	282.11	282.11	282.11	282.11	282.11	282.11
Additional Paid-In Capital	132.63	132.63	132.63	132.63	132.63	132.63
Retained Earnings	1,018	1,093	1,007	944.22	862.64	739.36
Comprehensive Income & Other	-4.16	6.84	2.93	4.96	-3.93	-3.44
Shareholders' Equity	1,429	1,515	1,425	1,364	1,273	1,151
Total Liabilities & Equity	1,949	1,935	1,817	1,713	1,641	1,482
Total Debt	4.88	7.46	7.68	4.88	10.24	9.64
Net Cash (Debt)	1,204	1,031	922.06	903.29	829.09	711.29
Net Cash Growth	8.74%	11.81%	2.08%	8.95%	16.56%	16.44%
Net Cash Per Share	42.63	36.49	32.63	31.95	29.33	25.16
Filing Date Shares Outstanding	28.16	28.21	28.21	28.21	28.21	28.21
Total Common Shares Outstanding	28.16	28.21	28.21	28.21	28.21	28.21
Working Capital	1,184	1,266	1,183	1,124	1,036	907.2
Book Value Per Share	50.75	53.69	50.51	48.35	45.14	40.79
Tangible Book Value	1,429	1,514	1,424	1,363	1,251	1,128
Tangible Book Value Per Share	50.74	53.66	50.46	48.31	44.36	40.00
Land	-	157.64	157.64	157.64	157.64	157.64
Buildings	-	88.02	88.02	87.84	87.84	87.57
Machinery	-	56.92	34.17	39.05	32.92	28.31
Leasehold Improvements	-	5.52	5.17	2.25	2.22	1.49

Source: S&P Global Market Intelligence. Standard template. Financial Sources.